Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Jaffe, E. S.
Right arrow Articles by Burg, G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Jaffe, E. S.
Right arrow Articles by Burg, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 8:S83-S84, 1997
© 1997 European Society for Medical Oncology

Report of the Symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma*

E. S. Jaffe1 and G. Burg2

1 Hematopathology Section, Laboratory of Pathology, Division of Clinical Sciences, National Cancer Institute Bethesda, MD, USA
2 Clinic of Dermatolog University Hospital Zurich, Switzerland

1Correspondence to: Dr. Elaine S. Jaffe Hematopathology Section Laboratory of Pathology Division of Clinical Sciences National Cancer Institute Bethesda, MD 20892, USA

The symposium discussed the pathobiology, classification, and treatment of cutaneous lymphomas. Drs. Burg and Kadin commented on the pathophysiology of mycosis fungoides/Sézary syndrome and cutaneous CD30+ lymphoproliferative disorders, respectively. A proposed classification of primary cutaneous lymphomas from the EORTC was presented by Drs. Kerl and Sterry. Dr. Jaffe presented a classification of cutaneous lymphomas based on the REAL classification. All speakers agreed that primary cutaneous lymphomas are usually distinctive in their clinical behavior and biology, and differ from their nodal counterparts. The symposium concluded with remarks from Drs. Vonderheid and Hoppe on the therapeutic approach to primary cutaneous lymphoid malignancies.

cutaneous lymphoma, T cell, B cell, lymphocyte biology, skin

* The US Government right to retain a non-exclusive, royalty-free licence in and to any copyright is acknowledged.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 BloodHome page
B. F. Skinnider, A. J. Elia, R. D. Gascoyne, L. H. Trumper, F. von Bonin, U. Kapp, B. Patterson, B. E. Snow, and T. W. Mak
Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma
Blood, January 1, 2001; 97(1): 250 - 255.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.